LabWAS reveals physiologic signatures associated with genetic risk for psychiatric disorders, offering new biological insights into their pathology.
Abstract
Background: Psychiatric disorders pose a significant public health burden, and their complex genetic architecture underlies multiple biological pathways, contributing to a lack of diagnostic biomarkers. Laboratory-Wide Association Studies (LabWAS) leverage electronic health record laboratory data as intermediary phenotypes to link genetic risk to physiology. Methods: Polygenic Scores (PGS) for 25 health-related, psychiatric, and substance use phenotypes were generated for individuals of African (AFR; N=10,473) and European (EUR, N=35,131) ancestry from the Penn Medicine Biobank. Laboratory data was prepared using the LabWAS pipeline, encompassing 78 laboratory tests and 6 vital signs. Linear regression models tested the association of each lab value with PGS adjusting for sex, age, and ten within-ancestry genetic principal components. Results: Four PGS were significantly associated with at least one laboratory value in AFR individuals and 22 PGS in EUR individuals. In EUR individuals, psychiatric PGS partitioned into three physiological profiles: anxiety, attention-deficit/hyperactivity disorder, major depressive disorder, and post-traumatic stress disorder shared a metabolic/inflammatory signature (higher BMI, glucose, and monocytes; lower high density lipoprotein cholesterol and oxygen saturation); anorexia nervosa, obsessive compulsive disorder, and schizophrenia were characterized by lower BMI; and bipolar disorder demonstrated a more circumscribed profile with lower electrolytes and renal makers. Substance use disorder PGS similarly clustered: tobacco use disorder and externalizing showed metabolic/inflammatory profiles; alcohol-related phenotypes showed lower red blood cell indices; and cannabis use disorder had a more circumscribed profile. Conclusions: LabWAS reveals physiologic signatures associated with genetic risk for psychiatric disorders, offering new biological insights into their pathology.
Background The association between cardiovascular disease (CVD) and mental health (MH) is well established. However, the shared genetic architecture and underlying causal relationships between these conditions remain insufficiently understood. Material and methods Summary statistics from Genome-wide association studies...
Quan-Ting Yin, Jun Zhao, Peng-Cheng Yi et al.· Global Medical Genetics· 0 citations
Standard polygenic risk scores capture overall genetic liability to coronary artery disease (CAD) but do not reveal the biological processes contributing to risk in an individual. Here, we applied data-driven latent factor decomposition to 526 genome-wide significant CAD-associated variants, using their associations wi...
J. Morze, K. Smith, M. Kierczak et al.· medRxiv· 0 citations
Background: Leading schizophrenia GWAS signals require evaluation of their pathological significance across diverse ancestries. rs10866912 reached genome-wide significance in our Indian ancestry GWAS of schizophrenia; its risk allele reduces expression of NAPRT, the rate-limiting enzyme in the brain’s principal NAD+-sy...
Lauren Jankowski, Sathish Periyasamy, P. Youssef et al.· Genes· 0 citations
The observed genetic correlations are consistent with shared genetic liability between DED and chronic pain, autoimmune, and psychiatric traits, but do not establish causal direction.
Bryan R. Gorman, Jaxon J. Huang, Peter B. Barr et al.· EBioMedicine· 0 citations
It is demonstrated that the CALLY index is causally associated with neurodegenerative, metabolic, and sleep disorders, supporting its role as a promising integrated biomarker for disease risk stratification and public health applications.
Ben Niu, Ming-Hui Xia, Jia-Xin Wu et al.· Zeitschrift für Induktive Ab...· 0 citations
For most diseases, whether PRS improves prediction beyond clinical data remains unknown, as existing evidence is concentrated in a handful of conditions with established risk models. Using 900,000 participants from UK Biobank and FinnGen, we developed and validated models for predicting 150 diseases and all-cause morta...
D. Usoltsev, I. Molotkov, N. Kolosov et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.